Fig. 2.

Myricetin inhibited the viability of human colorectal cancer cells. HCT116 and SW620 cells were treated with 0–400 μmol/L myricetin for 24 h, 48 h, and 72 h. Cell viability was analysed by means of a resazurin cell viability assay. Three replicate wells were set up in 96-well plates for each experimental group, and the experiment was repeated three times